<DOC>
	<DOCNO>NCT00964756</DOCNO>
	<brief_summary>In spite surgical chemotherapeutic advance , long term survival advance recurrent gynecologic cancer remain dismal curative treatment recurrent disease exist . Novel treatment strategy need . This study determine maximally tolerate dose toxicity associate intraperitoneal delivery infectivity enhance adenovirus express suicide gene gene allow image gene transfer . This vector give combination intravenous ganciclovir patient recurrent ovarian gynecological cancer .</brief_summary>
	<brief_title>A Study Infectivity Enhanced Suicide Gene Expressing Adenovirus Ovarian Cancer Patients With Recurrent Ovarian Other Selected Gynecologic Cancers</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<criteria>Patients must histologically document invasive epithelial ovarian , extraovarian , fallopian tube endometrial carcinoma . Patients must persistent recurrent disease standard debulking/staging surgery conventional therapy . Patients must evidence intraabdominal disease ; disease may measurable nonmeasurable . Patients must GOG performance status 0 , 1 , 2 , life expectancy great 3 month . Patients must adequate hematologic , renal , hepatic function define : WBC &gt; 3,000 ul Granulocytes &gt; 1,500 ul Platelets &gt; 100,000 Creatinine clearance &gt; 80 mg/dl serum creatinine &gt; 2.0 Serum transaminase &lt; 2.5 x upper limit normal Normal serum bilirubin PT/PTT/INR &lt; 1.5 x institutional ULN O2 saturation &gt; = 92 % Patients must 19 year old must sign informed consent Patients epithelial tumor low malignant potential , stromal tumor germ cell tumor ovary ineligible participate study . Patients site disease locate beyond abdominal cavity ineligible participate study . Patients pregnant lactate ineligible participate study . Patients GOG performance status 3 4 ineligible participate study . Patients active heart disease ( characterized angina , unstable arrhythmia , congestive heart failure EF &lt; 55 % , pulmonary hyper tension , active chronic debilitate pulmonary disease ( i.e. , active pneumonia , severe COPD , pulmonary edema , O2 saturation &lt; 92 % ) , coagulation disorder ( i.e . bleed disorder , therapeutic anti coagulant )</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>ovarian cancer</keyword>
	<keyword>Recurrent ovarian cancer gynecologic cancer</keyword>
</DOC>